Original ResearchPublished 9 October 2026Adverse reactions of immune checkpoint inhibitors combined with acetaminophen/non-steroidal anti-inflammatory drugs (NSAIDs): a pharmacovigilance analysis of drug–drug interactionsXiayang Ren · Lihui Xue · Yanfeng Wang · Jian XiaoFrontiers in Pharmacologydoi 10.3389/fphar.2026.1833275
Original ResearchPublished 12 August 2026InfoMedex: drug-drug interaction prediction via a multimodal CNN-transformer modelAndrew Disharoon · Shifi Pasupuleti · Clark Thurston · Matt Fiore · Sadie McKenzie · Alysia Smith · Aaron J. MasinoFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1841035
Original ResearchPublished 10 June 2026Comprehensive pharmacovigilance assessment of pairwise drug–drug interactions and acute pancreatitis in the FDA adverse event reporting system: focus on incretin-based drugsIssei Kazume · Kenji Onda · Sachiko Tanaka · Takashi Yokokawa · Kenichi SuzukiFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1827098
AntibioticsPublished 5 November 2025A case report of drug–drug interaction between voriconazole and simnotrelvir/ritonavirTingting Chen · Qingquan ZhangFrontiers in Antibioticsdoi 10.3389/frabi.2025.1705987
